Sign Up to like & get
recommendations!
0
Published in 2017 at "Netherlands Heart Journal"
DOI: 10.1007/s12471-017-1007-y
Abstract: In the routine treatment of coronary artery disease, balloon angioplasty has been replaced by stents. The use of bare-metal stents resulted in lower rates of restenosis and repeat revascularisations. Drug-eluting stents (DES), designed with thinner…
read more here.
Keywords:
first generation;
scaffold;
generation;
generation absorb ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "The Lancet"
DOI: 10.1016/s0140-6736(17)31871-8
Abstract: Celebrating its 40th anniversary, percutaneous coronary intervention has evolved from balloon angioplasty over bare metal stents to the routine use of drug-eluting stents. Coronary artery stents introduced in the late 1980s marked an important milestone…
read more here.
Keywords:
bvs;
meta;
thrombosis;
relative risk ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(17)34646-6
Abstract: BACKGROUND: In silico studies have provided robust evidence that stent design affects local hemodynamic forces, which appear as a major determinant of clinical outcomes following stent implantation. However, implications of different stent/scaffold configurations on local…
read more here.
Keywords:
endothelial shear;
mirage brms;
shear stress;
mirage ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Coronary Artery Disease"
DOI: 10.1097/mca.0000000000000518
Abstract: Background Everolimus-eluting bioresorbable vascular scaffold (BVS) (Absorb BVS; Abbott Vascular, Santa Clara, California, USA) technology emerged with the promise that late stent-related coronary events could be prevented and coronary artery vasomotion could be restored, returning…
read more here.
Keywords:
cocr ees;
scaffold thrombosis;
bioresorbable vascular;
thrombosis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "PLoS ONE"
DOI: 10.1371/journal.pone.0197119
Abstract: Background Bioresorbable Vascular Scaffolds (BVS) were introduced to overcome some of the limitations of drug-eluting stent (DES) for PCI. Data regarding the clinical outcomes of the BVS versus DES beyond 2 years are emerging. Objective…
read more here.
Keywords:
term;
term outcomes;
bvs versus;
mid term ... See more keywords